Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allograft vasculopathy versus atherosclerosis.

Maziar Rahmani1, Rani P Cruz, David J Granville

  • 1The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Providence Research Institute, Vancouver, British Columbia, Canada. bmcmanus@mrl.ubc.ca

Circulation Research
|October 14, 2006
PubMed
Summary

Cardiac allograft vasculopathy (CAV) limits heart transplant success by causing coronary atherosclerosis. Understanding CAV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effects of High-Thoracic Spinal Cord Injury on the Heart Transcriptome.

Journal of neurotrauma·2026
Same author

Skin in the claim: United States patenting process and tips for dermatologists.

The Journal of investigative dermatology·2026
Same author

Bioinformatics strategies and biomarker refinement using high-throughput transcriptome data in transplantation.

Frontiers in bioinformatics·2026
Same author

Broad-spectrum bactericidal synergy of silver-cannabichromene-cannabigerol triple combinations against healthcare-associated pathogens.

Journal of applied microbiology·2026
Same author

Granzyme B from mast cells contributes to choroidal neovascularization in a model of wet age-related macular degeneration.

Frontiers in immunology·2026
Same author

Omics BioAnalytics: an RShiny application for multimodal biomarker panel discovery and assessment.

Bioinformatics advances·2026

Area of Science:

  • Cardiovascular Science
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Heart transplantation (HTx) is a key therapy for heart failure, with atherosclerosis being a major cause of organ failure in recipients.
  • Long-term HTx success is hindered by cardiac allograft vasculopathy (CAV), a specific form of coronary atherosclerosis.
  • While immunosuppression has advanced, CAV remains a significant challenge.

Purpose of the Study:

  • To review current knowledge on risk factors for CAV.
  • To explore the pathophysiological similarities and differences between CAV and native atherosclerosis.
  • To elucidate the mechanisms underlying CAV development post-heart transplantation.

Main Methods:

  • Review of existing literature on heart transplantation, CAV, and atherosclerosis.

Related Experiment Videos

  • Analysis of immunologic and non-immunologic risk factors contributing to CAV.
  • Comparison of pathobiological pathways involved in CAV and other forms of arteriosclerosis.

    • Main Results:

    • CAV pathogenesis involves a complex interplay of immunologic and non-immunologic factors.
    • Key events include endothelial injury, altered permeability, and lipid accumulation in allograft arteries.
    • Vascular smooth muscle cell activation, migration, and proliferation contribute to luminal narrowing.

    Conclusions:

    • CAV shares similarities with native atherosclerosis but has distinct features.
    • Understanding CAV's unique pathophysiology is crucial for improving long-term heart transplant outcomes.
    • Targeting both immune and non-immune pathways may be necessary for CAV prevention and treatment.